Cargando…
Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study
BACKGROUND: Rare pathogenic variants in membrane-associated guanylate kinase (MAGUK) genes cause intellectual disability (ID) and have recently been associated with neuropsychiatric risk in the non-ID population. However, it is not known whether risk for psychiatric symptoms amongst individuals with...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369839/ https://www.ncbi.nlm.nih.gov/pubmed/25802558 http://dx.doi.org/10.1186/s11689-015-9105-x |
_version_ | 1782362798708228096 |
---|---|
author | Baker, Kate Scerif, Gaia Astle, Duncan E Fletcher, Paul C Raymond, F Lucy |
author_facet | Baker, Kate Scerif, Gaia Astle, Duncan E Fletcher, Paul C Raymond, F Lucy |
author_sort | Baker, Kate |
collection | PubMed |
description | BACKGROUND: Rare pathogenic variants in membrane-associated guanylate kinase (MAGUK) genes cause intellectual disability (ID) and have recently been associated with neuropsychiatric risk in the non-ID population. However, it is not known whether risk for psychiatric symptoms amongst individuals with ID due to MAGUK gene mutations is higher than expected for the degree of general intellectual impairment, nor whether specific cognitive differences are associated with disruption to this gene functional network. METHODS: This study addresses these two questions via behavioural questionnaires and cognitive testing, applying quantitative methods previously validated in populations with ID. We compared males with X-linked ID caused by mutations in three MAGUK genes (PAK3, DLG3, OPHN1; n = 9) to males with ID caused by mutations in other X chromosome genes (n = 17). Non-parametric and parametric analyses were applied as appropriate to data. RESULTS: Groups did not differ in age, global cognitive impairment, adaptive function or epilepsy prevalence. However, individuals with MAGUK gene mutations demonstrated significantly higher psychopathology risks, comprising elevated total problem behaviours, prominent hyperactivity and elevated scores on an autism screening checklist. Despite these overt difficulties, individuals in the MAGUK group performed more accurately than expected for age and intelligence quotient (IQ) on computerised tests of visual attention, convergent with mouse models of MAGUK loss-of-function. CONCLUSIONS: Our findings support a role for MAGUK genes in influencing cognitive parameters relevant to psychiatric risk. In addition to establishing clear patterns of impairment for this group, our findings highlight the importance of careful phenotyping after genetic diagnosis, showing that gene functional network disruptions can be associated with specific psychopathological risks and cognitive differences within the context of ID. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s11689-015-9105-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4369839 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43698392015-03-24 Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study Baker, Kate Scerif, Gaia Astle, Duncan E Fletcher, Paul C Raymond, F Lucy J Neurodev Disord Research BACKGROUND: Rare pathogenic variants in membrane-associated guanylate kinase (MAGUK) genes cause intellectual disability (ID) and have recently been associated with neuropsychiatric risk in the non-ID population. However, it is not known whether risk for psychiatric symptoms amongst individuals with ID due to MAGUK gene mutations is higher than expected for the degree of general intellectual impairment, nor whether specific cognitive differences are associated with disruption to this gene functional network. METHODS: This study addresses these two questions via behavioural questionnaires and cognitive testing, applying quantitative methods previously validated in populations with ID. We compared males with X-linked ID caused by mutations in three MAGUK genes (PAK3, DLG3, OPHN1; n = 9) to males with ID caused by mutations in other X chromosome genes (n = 17). Non-parametric and parametric analyses were applied as appropriate to data. RESULTS: Groups did not differ in age, global cognitive impairment, adaptive function or epilepsy prevalence. However, individuals with MAGUK gene mutations demonstrated significantly higher psychopathology risks, comprising elevated total problem behaviours, prominent hyperactivity and elevated scores on an autism screening checklist. Despite these overt difficulties, individuals in the MAGUK group performed more accurately than expected for age and intelligence quotient (IQ) on computerised tests of visual attention, convergent with mouse models of MAGUK loss-of-function. CONCLUSIONS: Our findings support a role for MAGUK genes in influencing cognitive parameters relevant to psychiatric risk. In addition to establishing clear patterns of impairment for this group, our findings highlight the importance of careful phenotyping after genetic diagnosis, showing that gene functional network disruptions can be associated with specific psychopathological risks and cognitive differences within the context of ID. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s11689-015-9105-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-27 2015 /pmc/articles/PMC4369839/ /pubmed/25802558 http://dx.doi.org/10.1186/s11689-015-9105-x Text en © Baker et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Baker, Kate Scerif, Gaia Astle, Duncan E Fletcher, Paul C Raymond, F Lucy Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study |
title | Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study |
title_full | Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study |
title_fullStr | Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study |
title_full_unstemmed | Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study |
title_short | Psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study |
title_sort | psychopathology and cognitive performance in individuals with membrane-associated guanylate kinase mutations: a functional network phenotyping study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369839/ https://www.ncbi.nlm.nih.gov/pubmed/25802558 http://dx.doi.org/10.1186/s11689-015-9105-x |
work_keys_str_mv | AT bakerkate psychopathologyandcognitiveperformanceinindividualswithmembraneassociatedguanylatekinasemutationsafunctionalnetworkphenotypingstudy AT scerifgaia psychopathologyandcognitiveperformanceinindividualswithmembraneassociatedguanylatekinasemutationsafunctionalnetworkphenotypingstudy AT astleduncane psychopathologyandcognitiveperformanceinindividualswithmembraneassociatedguanylatekinasemutationsafunctionalnetworkphenotypingstudy AT fletcherpaulc psychopathologyandcognitiveperformanceinindividualswithmembraneassociatedguanylatekinasemutationsafunctionalnetworkphenotypingstudy AT raymondflucy psychopathologyandcognitiveperformanceinindividualswithmembraneassociatedguanylatekinasemutationsafunctionalnetworkphenotypingstudy |